Astria Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -194,912 | -185,421 | -177,550 | -170,084 | -37,300 |
| Accounts payable and accrued liabilities | -1,965 | -2,947 | -2,900 | -1,712 | 347 |
| Other Working Capital | -3,305 | -5,146 | -3,868 | -3,669 | 3,367 |
| Other Operating Activity | 170,031 | 169,649 | 168,202 | 166,749 | 1,101 |
| Operating Cash Flow | $-30,151 | $-23,865 | $-16,116 | $-8,716 | $-32,485 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,000 | 20,000 | 20,000 | 20,000 | 6,333 |
| PPE Investments | -21 | -21 | -21 | -21 | -33 |
| Net Acquisitions | 6,466 | 6,466 | 6,466 | 6,466 | N/A |
| Investing Cash Flow | $-12,555 | $26,445 | $26,445 | $26,445 | $6,300 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 104,284 | 104,267 | 104,261 | 104,261 | 40,860 |
| Financing Cash Flow | $104,284 | $104,267 | $104,261 | $104,261 | $40,860 |
| Beginning Cash Position | 25,051 | 25,051 | 25,051 | 25,051 | 10,376 |
| End Cash Position | 86,629 | 131,898 | 139,641 | 147,041 | 25,051 |
| Net Cash Flow | $61,578 | $106,847 | $114,590 | $121,990 | $14,675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,151 | -23,865 | -16,116 | -8,716 | -32,485 |
| Capital Expenditure | -21 | -21 | -21 | -21 | -33 |
| Free Cash Flow | -30,172 | -23,886 | -16,137 | -8,737 | -32,518 |